Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2010
11/25/2010WO2010135541A2 Variants of c-type natriuretic peptide
11/25/2010WO2010135538A1 Botulinum toxin screening assays
11/25/2010WO2010135475A2 Phosphorylated fatty acid synthase and cancer
11/25/2010WO2010135468A1 Methods for providing personalized medicine tests ex vivo for hematological neoplasms
11/25/2010WO2010135431A2 Compositions, devices, and methods related to prostate-specific membrane antigen
11/25/2010WO2010135417A2 Multilayer colorimetric sensor arrays
11/25/2010WO2010135413A2 Multilayer colorimetric sensors
11/25/2010WO2010135391A2 An improved method for diagnosing or predicting short stature in humans
11/25/2010WO2010135364A2 Multi-directional microfluidic devices and methods
11/25/2010WO2010135354A1 Particles and methods for long wavelength sers
11/25/2010WO2010135351A1 Thermally stable sers taggants
11/25/2010WO2010135334A1 Methods of renal cancer detection
11/25/2010WO2010135330A1 Conjugate having cleavable linking agent
11/25/2010WO2010134871A1 Method, arrangement, drying chamber and drying plant
11/25/2010WO2010134814A2 Means and methods for counteracting polyq expansion disorders
11/25/2010WO2010134601A1 Peptide inducing xage-1b-specific immune reaction and utilization of same
11/25/2010WO2010134592A1 Plasmon excitation sensor for use in assay method based on spfs-lpfs system, and assay method
11/25/2010WO2010134567A1 Method for detection of free nucleic acid in blood
11/25/2010WO2010134506A1 Immunosensor for detecting explosive material and method for producing same
11/25/2010WO2010134505A1 Immunosensor for antimalarial drug and method for producing same
11/25/2010WO2010134373A1 Prophylactic and/or therapeutic agent for metabolic syndrome
11/25/2010WO2010134345A1 Blood coagulation time prolonging agent
11/25/2010WO2010134308A1 Biomarker for mental disorders including cognitive disorders, and method using said biomarker to detect mental disorders including cognitive disorders
11/25/2010WO2010134225A1 Method for detection of infection by pathogenic neisseria bacteria using partial sugar chain epitope, and vaccine against the bacteria
11/25/2010WO2010134150A1 Fuel viscosity detector
11/25/2010WO2010134073A1 Kits for and methods of differential staining of cervical cancer cells and/or tissues
11/25/2010WO2010134039A2 Mitochondrial activity inhibitors of cancer-initiating cells and use thereof
11/25/2010WO2010134005A1 Sensor device for magnetic particles with a high dynamic range
11/25/2010WO2010133997A1 Diagnostic device with sample application detector
11/25/2010WO2010133967A1 Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
11/25/2010WO2010133962A1 Methods for analyzing agricultural and environmental samples using microfluidic systems
11/25/2010WO2010133893A1 Method of producing a binding molecule
11/25/2010WO2010133881A2 Tissue analysis
11/25/2010WO2010133880A1 Assay methods for the determination of fkbpl expression level in the context of breast cancer
11/25/2010WO2010133831A1 Glucose sensor calibration
11/25/2010WO2010133776A2 Device and method for isolating biological or chemical targets
11/25/2010WO2010133655A1 Post-translation modified cardiac troponin t as a biomarker of a risk for heart failure
11/25/2010WO2010133589A1 Method for detecting a wound infection
11/25/2010WO2010133450A1 Device for an axial load gauge
11/25/2010WO2010133301A1 Method for analyzing axon growth
11/25/2010WO2010133194A1 Microorganism for expressing a human membrane protein
11/25/2010WO2010133173A1 Process for differential polypeptides detection and uses thereof
11/25/2010WO2010133001A1 Composite animal litter material and methods
11/25/2010WO2010132992A1 Compounds for the inhibition of herpesviruses
11/25/2010WO2010132982A1 Treatment of muscle disease characterized by insulin resistance
11/25/2010WO2010132958A1 Methods for predicting responsiveness to treatment
11/25/2010WO2010132957A1 Water analysis
11/25/2010WO2010132908A1 Method for the qualitative and/or quantitative analysis of tumour cells
11/25/2010WO2010114772A3 Fluorescence cued raman identification of viable organisms
11/25/2010WO2010113025A3 Diagnosis of gluten-induced autoimmune diseases
11/25/2010WO2010105850A3 Test element for determining a body fluid and measurement method
11/25/2010WO2010093151A3 Open-type groove channel chip
11/25/2010WO2010090844A3 Multipurpose analysis using second harmonic generating nanoprobes
11/25/2010WO2010090834A3 Netrin-1 as a biomarker of injury and disease
11/25/2010WO2010090810A3 Diagnostic device and method
11/25/2010WO2010090391A9 Turbidity-measuring probe having polymer membranes modified by a hydrophobic sol-gel
11/25/2010WO2010089538A3 Methods of detecting colorectal cancer
11/25/2010WO2010083204A3 Noninvasive measurement of flavonoid compounds in biological tissue
11/25/2010WO2010081076A3 Imprinted polymer nanoparticles
11/25/2010WO2010080994A3 Process for regulating immune response
11/25/2010WO2010080710A3 Sample collection and measurement in a single container by back scattering interferometry
11/25/2010WO2010080640A3 A ph modulation method to detect ligand-receptor binding
11/25/2010WO2010080007A3 Lipoproteins derived from gram-positive bacteria functioning as toll-like receptor 2 ligand
11/25/2010WO2010079994A3 Anti-cancer drug screening method using rorα
11/25/2010WO2010079345A3 Antibody-guided fragment growth
11/25/2010WO2010078403A3 Methods and compositions for diagnosing urological disorders
11/25/2010WO2010067984A3 Novel biomarker for liver cancer and applications for same
11/25/2010WO2010062903A3 Genomic sequencing using modified protein pores and ionic liquids
11/25/2010WO2010057020A3 Modification of amyloid-beta load in non-brain tissue
11/25/2010WO2010048615A3 Human ebola virus species and compositions and methods thereof
11/25/2010WO2010040003A3 Human a2a adenosine receptor crystals and uses thereof
11/25/2010US20100299767 Trem-2 gene and protein as inhibitors of expression of ga733-2, and transgenic animals comprising the same and uses thereof
11/25/2010US20100299766 Mouse models carrying a knock-out mutation of the qpctl-gene
11/25/2010US20100299765 Modalities for the treatment of degenerative diseases of the retina
11/25/2010US20100299085 Method for indicating fatigue damage of a metal object
11/25/2010US20100299080 Determination of oil deterioration and control and/or regulation of an internal combustion engine
11/25/2010US20100299075 Systems and methods for calculating an average analyte concentration value
11/25/2010US20100299072 Substrate concentration measurement method and substrate concentration measurement apparatus
11/25/2010US20100298649 System and methods for assessment of the aging brain and its brain disease induced brain dysfunctions by speech analysis
11/25/2010US20100298543 Mammalian zcytor 11
11/25/2010US20100298434 Neuroprotection and prevention of dopaminergic cell death by targeting nur77 translocation
11/25/2010US20100298418 Assay for measuring plasma FGL-2 and methods and uses thereof
11/25/2010US20100298404 Translocation and mutant ROS kinase in human non-small cell lung carcinoma
11/25/2010US20100298399 Endothelin Single Nucleotide Polymorphisms and Methods of Predicting B-Adrenergic Receptor Targeting Agent Efficacy
11/25/2010US20100298308 Compositions and methods for bone formation and remodeling
11/25/2010US20100298236 Soluble gp130 muteins with improved binding activity
11/25/2010US20100298234 Cancer therapeutic agents comprising a ligand for the neuromedin u receptor 2 (fm4) molecule as an active ingredient
11/25/2010US20100298200 Compounds and assays for controlling Wnt activity
11/25/2010US20100298169 Method of patterning molecules on a substrate using a micro-contact printing process
11/25/2010US20100298168 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/25/2010US20100298167 Novel cell lines expressing enac and methods using them
11/25/2010US20100298165 Bioarray chip reaction apparatus and its manufacture
11/25/2010US20100298164 Structure-based approach to design of inhibitors of protein-processivity factor interactions
11/25/2010US20100298161 Biomarkers for liver injury
11/25/2010US20100298158 Compositions, Kits, and Methods for Identification, Assessment, Prevention, and Therapy of Cancer
11/25/2010US20100298155 Antibodies specific to antigens of bartonella henselae and use of these antigens in immunoassays
11/25/2010US20100298151 Exosome-associated microrna as a diagnostic marker
11/25/2010US20100297780 Methods and systems for detecting
11/25/2010US20100297779 Biochip Self-Calibration Process
11/25/2010US20100297778 Conjugate Having Cleavable Linking Agent
1 ... 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 ... 3937